·
8 MIN READ

Oct. 20, 2023: National Advocacy Update

National Addiction Treatment Week underscores urgent need for comprehensive solutions to the overdose and death epidemic and more in the latest National Advocacy Update.

Advocacy Update
·
1 MIN READ

Oct. 20, 2023: Advocacy Update other news

Opioid overdose epidemic podcast series is now available and more in the latest Advocacy Update other news.

Advocacy Update
AMA Update for Oct. 16, 2023: Understanding addiction and treating patients with substance use disorders with Bobby Mukkamala, MD
·
12 MIN READ

Understanding addiction and treating patients with substance use disorders with Bobby Mukkamala, MD

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about substance use disorders and treatment.

series
Overdose Epidemic
AMA Update
·
12 MIN READ

Understanding addiction and treating patients with substance use disorders with Bobby Mukkamala, MD [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about substance use disorders and treatment.

series
Overdose Epidemic
AMA Update Podcast
·
1 MIN READ

AMA applauds DEA extending telehealth prescription flexibilities through 2024

The AMA applauds the DEA decision to extend flexibilities in the prescribing of controlled substances based on telehealth patient visits through December 31, 2024

Press Releases
·
2 MIN READ

Oct. 6, 2023: State Advocacy Update

WisMed, WISAM, AMA oppose bill authorizing the sale and marketing of kratom and more in the latest State Advocacy Update.

Advocacy Update
·
7 MIN READ

AMA in the News: September 2023

Read media highlights mentioning the American Medical Association for September 2023.

series
AMA in the News
AMA in the News
·
5 MIN READ

Top news stories from AMA Morning Rounds®: Week of Sept. 25, 2023

In the news: Recommendation on RSV vaccine for pregnant people, new insights on long COVID, warning added to Ozempic label and more.

Publications & Newsletters
Balanced pills and supplements
·
4 MIN READ

A handful of PBMs have nearly 70% share in 3 product markets

New evidence sheds light on the need for more transparency and oversight of pharmacy benefit manager (PBM) policies and practices. Learn more.

Access to Care